Cargando…

YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor α

Positive evidence from clinical trials has fueled growing acceptance of traditional Chinese medicine (TCM) for the treatment of cardiac diseases; however, little is known about the underlying mechanisms. Here, we investigated the nature and underlying mechanisms of the effects of YiXin-Shu (YXS), an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yichao, Xu, Longwei, Qiao, Zhiqing, Gao, Lingchen, Ding, Song, Ying, Xiaoying, Su, Yuanyuan, Lin, Nan, He, Ben, Pu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786861/
https://www.ncbi.nlm.nih.gov/pubmed/26964694
http://dx.doi.org/10.1038/srep23025
_version_ 1782420615518486528
author Zhao, Yichao
Xu, Longwei
Qiao, Zhiqing
Gao, Lingchen
Ding, Song
Ying, Xiaoying
Su, Yuanyuan
Lin, Nan
He, Ben
Pu, Jun
author_facet Zhao, Yichao
Xu, Longwei
Qiao, Zhiqing
Gao, Lingchen
Ding, Song
Ying, Xiaoying
Su, Yuanyuan
Lin, Nan
He, Ben
Pu, Jun
author_sort Zhao, Yichao
collection PubMed
description Positive evidence from clinical trials has fueled growing acceptance of traditional Chinese medicine (TCM) for the treatment of cardiac diseases; however, little is known about the underlying mechanisms. Here, we investigated the nature and underlying mechanisms of the effects of YiXin-Shu (YXS), an antioxidant-enriched TCM formula, on myocardial ischemia/reperfusion (MI/R) injury. YXS pretreatment significantly reduced infarct size and improved viable myocardium metabolism and cardiac function in hypercholesterolemic mice. Mechanistically, YXS attenuated myocardial apoptosis by inhibiting the mitochondrial mediated apoptosis pathway (as reflected by inhibition of mitochondrial swelling, cytochrome c release and caspase-9 activity, and normalization of Bcl-2 and Bax levels) without altering the death receptor and endoplasmic reticulum-stress death pathways. Moreover, YXS reduced oxidative/nitrative stress (as reflected by decreased superoxide and nitrotyrosine content and normalized pro- and anti-oxidant enzyme levels). Interestingly, YXS upregulated endogenous nuclear receptors including LXRα, PPARα, PPARβ and ERα, and in-vivo knockdown of cardiac-specific LXRα significantly blunted the cardio-protective effects of YXS. Collectively, these data show that YXS is effective in mitigating MI/R injury by suppressing mitochondrial mediated apoptosis and oxidative stress and by upregulating LXRα, thereby providing a rationale for future clinical trials and clinical applications.
format Online
Article
Text
id pubmed-4786861
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-47868612016-03-14 YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor α Zhao, Yichao Xu, Longwei Qiao, Zhiqing Gao, Lingchen Ding, Song Ying, Xiaoying Su, Yuanyuan Lin, Nan He, Ben Pu, Jun Sci Rep Article Positive evidence from clinical trials has fueled growing acceptance of traditional Chinese medicine (TCM) for the treatment of cardiac diseases; however, little is known about the underlying mechanisms. Here, we investigated the nature and underlying mechanisms of the effects of YiXin-Shu (YXS), an antioxidant-enriched TCM formula, on myocardial ischemia/reperfusion (MI/R) injury. YXS pretreatment significantly reduced infarct size and improved viable myocardium metabolism and cardiac function in hypercholesterolemic mice. Mechanistically, YXS attenuated myocardial apoptosis by inhibiting the mitochondrial mediated apoptosis pathway (as reflected by inhibition of mitochondrial swelling, cytochrome c release and caspase-9 activity, and normalization of Bcl-2 and Bax levels) without altering the death receptor and endoplasmic reticulum-stress death pathways. Moreover, YXS reduced oxidative/nitrative stress (as reflected by decreased superoxide and nitrotyrosine content and normalized pro- and anti-oxidant enzyme levels). Interestingly, YXS upregulated endogenous nuclear receptors including LXRα, PPARα, PPARβ and ERα, and in-vivo knockdown of cardiac-specific LXRα significantly blunted the cardio-protective effects of YXS. Collectively, these data show that YXS is effective in mitigating MI/R injury by suppressing mitochondrial mediated apoptosis and oxidative stress and by upregulating LXRα, thereby providing a rationale for future clinical trials and clinical applications. Nature Publishing Group 2016-03-11 /pmc/articles/PMC4786861/ /pubmed/26964694 http://dx.doi.org/10.1038/srep23025 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Zhao, Yichao
Xu, Longwei
Qiao, Zhiqing
Gao, Lingchen
Ding, Song
Ying, Xiaoying
Su, Yuanyuan
Lin, Nan
He, Ben
Pu, Jun
YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor α
title YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor α
title_full YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor α
title_fullStr YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor α
title_full_unstemmed YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor α
title_short YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor α
title_sort yixin-shu, a shengmai-san-based traditional chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-x-receptor α
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786861/
https://www.ncbi.nlm.nih.gov/pubmed/26964694
http://dx.doi.org/10.1038/srep23025
work_keys_str_mv AT zhaoyichao yixinshuashengmaisanbasedtraditionalchinesemedicineformulaattenuatesmyocardialischemiareperfusioninjurybysuppressingmitochondrialmediatedapoptosisandupregulatingliverxreceptora
AT xulongwei yixinshuashengmaisanbasedtraditionalchinesemedicineformulaattenuatesmyocardialischemiareperfusioninjurybysuppressingmitochondrialmediatedapoptosisandupregulatingliverxreceptora
AT qiaozhiqing yixinshuashengmaisanbasedtraditionalchinesemedicineformulaattenuatesmyocardialischemiareperfusioninjurybysuppressingmitochondrialmediatedapoptosisandupregulatingliverxreceptora
AT gaolingchen yixinshuashengmaisanbasedtraditionalchinesemedicineformulaattenuatesmyocardialischemiareperfusioninjurybysuppressingmitochondrialmediatedapoptosisandupregulatingliverxreceptora
AT dingsong yixinshuashengmaisanbasedtraditionalchinesemedicineformulaattenuatesmyocardialischemiareperfusioninjurybysuppressingmitochondrialmediatedapoptosisandupregulatingliverxreceptora
AT yingxiaoying yixinshuashengmaisanbasedtraditionalchinesemedicineformulaattenuatesmyocardialischemiareperfusioninjurybysuppressingmitochondrialmediatedapoptosisandupregulatingliverxreceptora
AT suyuanyuan yixinshuashengmaisanbasedtraditionalchinesemedicineformulaattenuatesmyocardialischemiareperfusioninjurybysuppressingmitochondrialmediatedapoptosisandupregulatingliverxreceptora
AT linnan yixinshuashengmaisanbasedtraditionalchinesemedicineformulaattenuatesmyocardialischemiareperfusioninjurybysuppressingmitochondrialmediatedapoptosisandupregulatingliverxreceptora
AT heben yixinshuashengmaisanbasedtraditionalchinesemedicineformulaattenuatesmyocardialischemiareperfusioninjurybysuppressingmitochondrialmediatedapoptosisandupregulatingliverxreceptora
AT pujun yixinshuashengmaisanbasedtraditionalchinesemedicineformulaattenuatesmyocardialischemiareperfusioninjurybysuppressingmitochondrialmediatedapoptosisandupregulatingliverxreceptora